HiRO
Providing a Platform to Empower Better, Faster, and Economical Clinical Trials

Karen Chu, CEO

Harvest Integrated Research Organization (HiRO), a clinical research organization (CRO) dedicated to providing its sponsors with speedy and economical clinical trials through its project management, quality audits, and strategic planning services. It assists clients in opportunity assessment, funding, global clinical trial design and clinical development planning (CDP), efficient implementation, all the way through to commercial launch.

Transforming Trial Management through Expertise-Based and Client-friendly Services

Typically, biotech companies understand the hurdles that limited resources can bring to their drug discovery and clinical trials operations. HiRO accelerates decision-making for such companies with the agility required to effectively traverse the ever-evolving drug development arena. It offers knowledge-based consulting, from the beginning of early stage to help sponsors find the best way to proceed. HiRO also provides awareness on the capital market to boost fundraising opportunities for relevant stakeholders.

“We are considered a boutique CRO. We cater to SMBs and multinational organizations seeking to do cross-border regulatory submissions/applications and clinical trials execution by providing knowledge-based consultations that offer real value,” says Karen Chu, CEO of HiRO.

We offer cutting-edge training to our clinical research team, improving their productivity, and enabling highly collaborative engagement with customer’s teams

A Holistic and Tech-Driven Client Engagement Approach

HiRO begins every client engagement by engaging with the firms at the discovery stage, assisting in the in-depth evaluation of assets and datasets, and offering strategic development consultancy. By supporting the execution of early-stage tasks, the company boosts efficiencies throughout the overall drug development cycle and improves go-to-market time.

HiRO fulfills its goals by relying on its experienced management team that boosts the day-to-day operations by acting as executives and sponsors to oversight the quality of projects. At the same time, it offers cutting-edge trainings to its clinical research team, improving their productivity and enabling highly collaborative engagement with customer’ teams.

HiRO categorizes biotechs into different groups and addresses their distinct needs in a highly intuitive manner. The first category includes startups and smaller firms where most clients are at the preclinical stage, perfectly poised for HiRO to unlock efficiencies through its consultant expertise. For startups, it reviews the chemistry, manufacturing, and controls (CMC) of clinical trials, along with their protocol, and performs robust strategy development to help them choose the country best suited for their first in human study. With a host of such complete offerings in a single package, HiRO ensures a fast and cost-efficient way of achieving the groundwork as it increases the company’s current and future compound value.

HiRO’s “one global team” model is driven by a dedicated team of experts committed to providing rapid, reliable, and cost-effective solutions. The team facilitates a tailored-made client experience with a high level of interaction. It leverages its flexibility and agility to help biotechs manage various international requirements and regulations avoiding conventional hurdles. Through its vast experience and collaborative approach, with local and global partners working hand-in-hand with clients, HiRO supports biotechs in navigating the complex journey from laboratory to NDA/or commercialization.

Concurrently, HiRO’s global reach across China, the U.S., and Europe enables it to be a reliable partner for biotechs and pharma firms seeking to establish a footprint in these regions and maximize its access to patients. Within China, where new, streamlined and accelerated clinical processes are significantly trying to reduce start-up timelines, HiRO is supporting local and multinational organizations in capitalizing on these rising opportunities.

The global biopharmaceutical market is positioned to witness rapid growth powered by evolving technology and innovation, favorable government policy changes/reform/or upgrade, and increasing investment in research and development (R&D). With such prospects on the horizon, HiRO’s unique East-West geographical reach and global vision will enable it to continue being a leading CRO that supports biotechs of all sizes in reaping the benefits of having a Global Partner.